BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

539938

MIL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Medico Intercontinental Limite Share Price Update

As of the latest trading session, Medico Intercontinental Limite share price is currently at ₹ 38.1, which is up by ₹ 0.12 from its previous closing. Today, the stock has fluctuated between ₹ 37.75 and ₹ 38.39. Over the past year, Medico Intercontinental Limite has achieved a return of -15.50 %. In the last month alone, the return has been 1.44 %. Read More...

Medico Intercontinental Limite fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    38.10

  • P/E Ratio (TTM)

    15.19

  • Beta

    0.48

  • Book Value / share

    37.58

  • Return on equity

    5.40%

  • EPS (TTM)

    2.50

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.55

info icon alternate text

Medico Intercontinental Limite Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 11.43
Operating Expense 10.85
Net Profit 0.55
Net Profit Margin (%) 4.81
Earnings Per Share (EPS) 0.55
EBITDA 1.09
Effective Tax Rate (%) 27.99
Particulars SEP 2024 (Values in Cr)
Revenue 28.94
Operating Expense 27.59
Net Profit 0.99
Net Profit Margin (%) 3.42
Earnings Per Share (EPS) 0.99
EBITDA 1.77
Effective Tax Rate (%) 31.72
Particulars JUN 2024 (Values in Cr)
Revenue 11.52
Operating Expense 10.93
Net Profit 0.50
Net Profit Margin (%) 4.34
Earnings Per Share (EPS) 0.50
EBITDA 0.80
Effective Tax Rate (%) 27.94
Particulars MAR 2024 (Values in Cr)
Revenue 10.00
Operating Expense 9.37
Net Profit 0.47
Net Profit Margin (%) 4.70
Earnings Per Share (EPS) 0.47
EBITDA 0.80
Effective Tax Rate (%) 28.78
Particulars DEC 2023 (Values in Cr)
Revenue 7.33
Operating Expense 6.76
Net Profit 0.48
Net Profit Margin (%) 6.54
Earnings Per Share (EPS) 0.48
EBITDA 0.77
Effective Tax Rate (%) 27.69
Particulars MAR 2024 (Values in Cr)
Revenue 44.04
Operating Expense 41.83
Net Profit 1.90
Net Profit Margin (%) 4.31
Earnings Per Share (EPS) 1.90
EBITDA 3.02
Effective Tax Rate (%) 27.86
Particulars MAR 2023 (Values in Cr)
Revenue 48.88
Operating Expense 46.84
Net Profit 1.70
Net Profit Margin (%) 3.47
Earnings Per Share (EPS) 1.70
EBITDA 2.84
Effective Tax Rate (%) 28.15
Particulars MAR 2022 (Values in Cr)
Revenue 39.25
Operating Expense 37.60
Net Profit 1.31
Net Profit Margin (%) 3.33
Earnings Per Share (EPS) 4.04
EBITDA 2.45
Effective Tax Rate (%) 28.41
Particulars MAR 2021 (Values in Cr)
Revenue 41.02
Operating Expense 39.53
Net Profit 1.20
Net Profit Margin (%) 2.92
Earnings Per Share (EPS) 3.68
EBITDA 2.50
Effective Tax Rate (%) 28.31
Particulars MAR 2020 (Values in Cr)
Revenue 46.93
Operating Expense 45.43
Net Profit 1.12
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 3.44
EBITDA 2.22
Effective Tax Rate (%) 27.27
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.03
ROE % 9.16
ROCE % 12.37
Total Debt to Total Equity 0.11
EBITDA Margin 8.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 41.19
ROE % 13.41
ROCE % 16.53
Total Debt to Total Equity 0.25
EBITDA Margin 7.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.89
ROE % 27.95
ROCE % 25.40
Total Debt to Total Equity 0.81
EBITDA Margin 7.16
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.35
ROE % 32.45
ROCE % 24.80
Total Debt to Total Equity 1.44
EBITDA Margin 7.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 19.58
ROE % 45.56
ROCE % 35.72
Total Debt to Total Equity 1.33
EBITDA Margin 5.38
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.10
ROE % 5.40
ROCE % 7.73
Total Debt to Total Equity 0.05
EBITDA Margin 6.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.30
ROE % 8.10
ROCE % 10.86
Total Debt to Total Equity 0.20
EBITDA Margin 5.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 23.55
ROE % 18.73
ROCE % 18.78
Total Debt to Total Equity 0.79
EBITDA Margin 6.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 19.51
ROE % 20.89
ROCE % 19.71
Total Debt to Total Equity 1.16
EBITDA Margin 6.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 15.84
ROE % 24.40
ROCE % 24.69
Total Debt to Total Equity 0.94
EBITDA Margin 4.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.36
Total Assets 56.04
Total Liabilities 56.04
Total Equity 45.03
Share Outstanding 10000000
Price to Book Ratio 1.10
Return on Assets (%) 7.04
Return on Capital (%) 7.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.78
Total Assets 58.87
Total Liabilities 58.87
Total Equity 41.18
Share Outstanding 10000000
Price to Book Ratio 2.42
Return on Assets (%) 6.12
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.86
Total Assets 31.92
Total Liabilities 31.92
Total Equity 12.63
Share Outstanding 3249000
Price to Book Ratio 2.47
Return on Assets (%) 9.70
Return on Capital (%) 14.57
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 30.64
Total Liabilities 30.64
Total Equity 9.53
Share Outstanding 3249000
Price to Book Ratio 1.31
Return on Assets (%) 8.40
Return on Capital (%) 13.93
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 36.04
Total Liabilities 36.04
Total Equity 6.36
Share Outstanding 3249000
Price to Book Ratio 0.98
Return on Assets (%) 6.53
Return on Capital (%) 12.09
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.40
Total Assets 39.44
Total Liabilities 39.44
Total Equity 36.09
Share Outstanding 10000000
Price to Book Ratio 1.10
Return on Assets (%) 4.80
Return on Capital (%) 5.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.94
Total Assets 44.37
Total Liabilities 44.37
Total Equity 34.29
Share Outstanding 10000000
Price to Book Ratio 2.42
Return on Assets (%) 3.84
Return on Capital (%) 4.66
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 17.71
Total Liabilities 17.71
Total Equity 7.65
Share Outstanding 3249000
Price to Book Ratio 2.47
Return on Assets (%) 7.40
Return on Capital (%) 9.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 16.42
Total Liabilities 16.42
Total Equity 6.34
Share Outstanding 3249000
Price to Book Ratio 1.31
Return on Assets (%) 7.27
Return on Capital (%) 10.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 19.17
Total Liabilities 19.17
Total Equity 5.14
Share Outstanding 3249000
Price to Book Ratio 0.98
Return on Assets (%) 5.83
Return on Capital (%) 8.18
Particulars MAR 2024 (Values in Cr)
Net Income 5.43
Cash from Operations 6.87
Cash from Investing -8.53
Cash from Financing -0.45
Net change in Cash -3.42
Free Cash Flow 8.11
Particulars MAR 2023 (Values in Cr)
Net Income 4.94
Cash from Operations -8.80
Cash from Investing -5.38
Cash from Financing 20.40
Net change in Cash 4.92
Free Cash Flow -8.38
Particulars MAR 2022 (Values in Cr)
Net Income 4.23
Cash from Operations 5.01
Cash from Investing -1.29
Cash from Financing -1.20
Net change in Cash 1.35
Free Cash Flow 5.22
Particulars MAR 2021 (Values in Cr)
Net Income 3.53
Cash from Operations 6.59
Cash from Investing -0.94
Cash from Financing -5.14
Net change in Cash -0.26
Free Cash Flow 6.80
Particulars MAR 2020 (Values in Cr)
Net Income 3.20
Cash from Operations -8.73
Cash from Investing 0.00
Cash from Financing 13.42
Net change in Cash -0.40
Free Cash Flow -8.73
Particulars MAR 2024 (Values in Cr)
Net Income 2.62
Cash from Operations 6.34
Cash from Investing -6.64
Cash from Financing -1.62
Net change in Cash -2.54
Free Cash Flow 6.37
Particulars MAR 2023 (Values in Cr)
Net Income 2.37
Cash from Operations -11.29
Cash from Investing -5.02
Cash from Financing 20.63
Net change in Cash 3.66
Free Cash Flow -10.92
Particulars MAR 2022 (Values in Cr)
Net Income 1.82
Cash from Operations 1.72
Cash from Investing -0.79
Cash from Financing 0.87
Net change in Cash 1.16
Free Cash Flow 1.78
Particulars MAR 2021 (Values in Cr)
Net Income 1.66
Cash from Operations 5.91
Cash from Investing -0.94
Cash from Financing -4.51
Net change in Cash -0.02
Free Cash Flow 6.09
Particulars MAR 2020 (Values in Cr)
Net Income 1.53
Cash from Operations -6.29
Cash from Investing -3.68
Cash from Financing 9.22
Net change in Cash -1.01
Free Cash Flow -6.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 48.02 6.73 27760.59 574.70 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.29 2147.57 3.82 / 276.45
MYSORE PETRO CHEMICALS LTD. 122.85 6.28 0.35 80.88 117.45 / 261.90
OSWAL AGRO MILLS LTD 84.43 22.28 1.34 1133.30 41.50 / 108.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 64.67 11.07 27760.59 574.70 / 1035.70
UTIQUE ENTERPRISES LIMITED 4.66 18.64 0.35 25.94 3.77 / 10.88
COMPUTER POINT LTD. 5.08 0.00 0.45 15.24 4.24 / 11.63
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.31 2147.57 3.82 / 276.45

Medico Intercontinental Limite Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
37.84 -0.34 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 37.90
  • 26 Days 39.10
  • 10 Days 38.20
  • 50 Days 40.70
  • 12 Days 38.30
  • 100 Days 43.40
  • 20 Days 38.80
  • 200 Days 47.60
37.42 PIVOT

First Support

36.85

First Resistance

38.54

Second Support

35.73

Second Resistance

39.11

Third Support

35.16

Third Resistance

40.23

RSI

45.48

ADX

24.65

MACD

-0.78

Williams % R

-60.60

Commodity Channel Index (CCI)

-81.29

Date

2025-04-29

Week

4032.00

Same Day

3697.00

Month

4334.00

1 Year

0.48

3 Year

0.20

Over 1 Month

1.44%

down

Over 1 Year

-15.50%

down

Over 3 Months

-17.33%

down

Over 3 Years

-6.46%

down

Over 6 Months

-16.60%

down

Over 5 Years

20.81%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Medico Intercontinental Limite shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
44.82%
Promoter Holdings
55.17%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Shah Samir 4442828.0 (44.43%) Shareholding of Promoter and Promoter Group
Dilipkumar Bhogilal Shah 1074397.0 (10.74%) Shareholding of Promoter and Promoter Group
Lalita . 150000.0 (1.5%) Public Shareholding
Dd Master Huf . 123575.0 (1.24%) Public Shareholding

News

Left Arrow
Right Arrow

Medico Intercontinental Limite corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
23 Jun 2023 0.1 Final 23 Jun 2023 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Medico Intercontinental Limite Share Price

Medico Intercontinental Limited (Formerly known as Intercontinental Leasing & Finance Company Limited) was incorporated on August 14, 1984 in Ahmedabad, India. The Company changed its name to 'Medico Intercontinental Limited' in December, 2018. The Company is involved in trading of pharmaceutical products.

The Company is also providing a platform to all research based bio-pharmaceutical companies reaching their novel and innovative therapies to every part of the globe. From helping people obtain their medications to using cutting-edge scientific technology to discover new treatments, Medico's entrepreneurial spirit, teamwork-oriented culture and commitment to rare diseases create a unique platform for transforming patient outcomes. The Company's commitment to changing the course of human health through bold pursuits in science, life-enhancing therapies and a promise to always put patients first across the continents.

Parent organization Indian Private
NSE symbol [-]
Founded 1984
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Medico Intercontinental Ltd?

Answer Field

The share price of Medico Intercontinental Ltd for NSE is ₹ 0.00 and for BSE is ₹ 37.84.

What is the Market Cap of Medico Intercontinental Ltd?

Answer Field

The market cap of Medico Intercontinental Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 37.80 Cr. as of now.

What is the 52 Week High and Low of Medico Intercontinental Ltd?

Answer Field

The 52 Week High and Low of Medico Intercontinental Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 63.59 and ₹ 34.21.

How to Buy Medico Intercontinental Ltd share?

Answer Field

You can trade in Medico Intercontinental Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medico Intercontinental Ltd?

Answer Field

The 1 year returns on the stock has been -15.50%.

What is the Current Share Price of Medico Intercontinental Ltd?

Answer Field

Medico Intercontinental Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.84 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Medico Intercontinental Ltd Share?

Answer Field

The market cap of Medico Intercontinental Ltd for NSE ₹ 0.0 & for BSE ₹ 37.80 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Medico Intercontinental Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Medico Intercontinental Ltd share is 15.19.

What is the PB ratio of Medico Intercontinental Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Medico Intercontinental Ltd share is 37.58.

How to Buy Medico Intercontinental Ltd Share?

Answer Field

You can trade in Medico Intercontinental Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Intercontinental Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Intercontinental Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Intercontinental Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|